| | | | | |

Spice Compound Extends Mesothelioma Survival in Mice

815355_turmericThe compound that gives the spice turmeric its yellow color and pungent flavor is once again attracting the attention of mesothelioma researchers.

Curcumin has been the subject of numerous mesothelioma studies. The latest one, conducted by scientists at the Department of Experimental Medicine at the University of Rome, finds that the compound has the power to not only kill mesothelioma cells in the lab, but to also extend survival in mice infected with the asbestos cancer.

Curcumin in the Treatment of Mesothelioma

Curcumin is a plant-derived polyphenol with anti-inflammatory and antioxidant properties. It can be taken in pill form and, unlike most drugs that treat malignant mesothelioma, has virtually no side effects.

The new Italian study tests curcumin’s potential value as a mesothelioma treatment in two ways. First , the compound was applied to several different human mesothelioma cells lines and to mouse mesothelioma cells in the lab (in vitro). The results were significant.

“Curcumin in vitro inhibited malignant mesothelioma cells survival in a dose- and time-dependent manner and increased reactive oxygen species’ intracellular production and induced DNA damage,” writes researcher and lead author Dr. Laura Masuelli in the medical journal Oncotarget.

Reactive oxygen species are chemically reactive particles that contain oxygen. Although they are a natural byproduct of metabolism, a significant rise in ROS can damage cells. The same is true for DNA damage, which makes it impossible for cells, including mesothelioma cells, to replicate successfully.

The combination of damaging effects triggered a process of cellular death among mesothelioma cells in the lab called apoptosis.

Testing Curcumin in Live Mice with Mesothelioma

The second way in which the Italian research team tested the mesothelioma-fighting properties of curcumin was to administer it to live mice that had been infected with human peritoneal mesothelioma.

When curcumin was administered directly into the peritoneal cavity, the space between the membranes that surround the abdominal organs, the mice had a longer median survival time. Equally significantly, curcumin appeared to reduce the risk of developing new mesothelioma tumors.

“Our findings may have important implications for the design of malignant mesothelioma treatment using curcumin,” the report concludes.

Curcumin as an Alternative Mesothelioma Therapy

In 2015, mesothelioma researchers with Flinders University in Australia determined that curcumin had the ability to keep mesothelioma tumors from giving rise to their own new blood vessels. It was suggested that curcumin could become a supplemental treatment for certain mesothelioma patients.

In another 2015 study, Italian researchers found that curcumin was even more effective when delivered into mesothelioma cells via nanoparticles, which overcame the cells’ natural resistance to the compound.

Alternative mesothelioma therapies like curcumin are of particular interest to mesothelioma researchers because of the cancer’s resistance to standard treatments. As many as 2,500 people died of mesothelioma in the US each year.

Sources:

Masuelli, L, “Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line”, January 30, 2017, Oncotarget, Epub ahead of print

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…